Foghorn Therapeutics (FHTX) Non Operating Income (2019 - 2026)
Foghorn Therapeutics' Non Operating Income came in at $1.61 million for Q2 2026, down 48.9% from $3.16 million a year earlier and down 4.9% from the prior quarter.
Foghorn Therapeutics (FHTX) Non Operating Income (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Foghorn Therapeutics reported Non Operating Income of $8.18 million, down 50.4% year-over-year; for FY2025, it was $12.11 million, down 24.6% from FY2024.
- Going back by year, Non Operating Income was $16.06 million in FY2024 (+17.2%), $13.71 million in FY2023 (+66.0%), $8.26 million in FY2022 and -$586,000 in FY2021.
- The Q2 2026 figure represents the lowest quarterly Non Operating Income since Q1 2022.
- Year-over-year, Non Operating Income has declined for five consecutive quarters, with an average decline of 14.5% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in Q1 2022 (growth of 518.1%), and the weakest in Q1 2026 (a decline of 58.4%).
- Business Quant data shows FHTX's Non Operating Income at $1.7 million (Q1 2026), $2.21 million (Q4 2025) and $2.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Foghorn Therapeutics | 209.61 Mn | -116.34 Mn | - | 1.61 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.73 Mn |
| Jun 30, 2024 | 3.65 Mn |
| Mar 31, 2024 | 3.18 Mn |
| Dec 31, 2023 | 3.34 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 3.51 Mn |
| Mar 31, 2023 | 3.39 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 2.49 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 890,000.00 |
| Dec 31, 2021 | -1.06 Mn |
| Sep 30, 2021 | 181,000.00 |
Foghorn Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=FHTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "FHTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=FHTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();